Device type · LSE
Epstein-Barr Virus, Other
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LSE
Microbiology
Device class
Class I
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
2
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Epstein-Barr Virus, Other
- Product code
- LSE
- Device class
- Class I
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3235
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for LSE
Latest FDA decisions
- Elecsys EBV EBNA IgG510(k)
K260221 · Decided Oct 2, 2026 · 249 days after receipt
Device type: Epstein-Barr Virus, Other (LSE) · Laboratory Medicine & Pathology
- Elecsys EBV VCA IgG510(k)
K260232 · Decided Oct 2, 2026 · 249 days after receipt
Device type: Epstein-Barr Virus, Other (LSE) · Laboratory Medicine & Pathology
K233606 · Decided Aug 7, 2024 · 272 days after receipt
Device type: Epstein-Barr Virus, Other (LSE) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Reports received
2
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
2
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 2 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Epstein-Barr Virus (EBV VCA & EBNA IgG) TestOpen, Classified
Z-0735-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
Z-1686-2016 · Started Oct 20, 2014
Reason given: A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2082-2011 · Started Mar 11, 2011 · Posted by FDA Apr 27, 2011
Reason given: Bio-Rad Laboratories confirmed a downward shift in control values for EBV NA-1 analyte when using the BioPlex 2200 EBV IgG Calibrator Set Lot #46704.
Cause as FDA categorized it: Other
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.